Renaissance Capital logo

Hillstream BioPharma Priced, Nasdaq: HILS

Preclinical biotech developing therapies for solid tumors by targeting ferroptosis.

Industry: Health Care

Latest Trade: $0.51 +0.27 (+119.1%)

First Day Return: -13.0%

Return from IPO: -94.2%

Industry: Health Care

Hillstream BioPharma is a pre-clinical biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (“IMCD”) for treatment resistant cancers. Our most advanced product candidate is HSB-1216, an IMCD inducer, targeting a variety of solid tumors. In a clinical pilot study conducted in Germany by the University of Heidelberg, the active drug in HSB-1216 was found to reduce tumor burden in treatment resistant cancers, including triple negative breast cancer (“TNBC”) and epithelial carcinomas. Our goal is to submit an investigational new drug application (“IND”) to the U.S. Food and Drug Administration (“FDA”) in 2022 and start a clinical study with HSB-1216 in 2022; however, no assurance can be provided that our IND will be accepted by the FDA in 2022, if at all. If our IND is accepted by the FDA, our HSB-1216 clinical study will focus on expanding upon the clinical pilot study conducted in Germany. If we are able to start our clinical study with HSB-1216 in 2022, we anticipate that initial data from such trial will be released either the end of 2022 or early 2023. We use Quatramer, our proprietary tumor targeting platform, to enhance the uptake of HSB-1216 in the tumor microenvironment (“TME”) with an extended duration of action and minimal off-target toxicity.
more less
IPO Data
IPO File Date 09/27/2021
Offer Price $4.00
Price Range $5.00 - $6.00
Offer Shares (mm) 3.8
Deal Size ($mm) $15
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 01/11/2022
Offer Price $4.00
Price Range $5.00 - $6.00
Offer Shares (mm) 3.8
Deal Size ($mm) $15
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
ThinkEquity
Company Data
Headquarters Bridgewater, NJ, United States
Founded 2017
Employees 2
Website www.hillstreambio.com

Hillstream BioPharma (HILS) Performance